ALPFA Boston Healthcare Summit
Tell a Friend About This EventTell a Friend
ALPFA Boston Healthcare Summit

The 7th annual ALPFA Healthcare Summit on November 9th will be one of ALPFA Boston’s largest annual events. Each year, the ALPFA Healthcare Summit gathers hundreds of professionals to discuss hot topics in healthcare and life sciences.

When: 11/09/2017
From 5:00 PM until 9:00 PM
Where: MassDOT
10 Park Plaza
Executive Room
Boston, Massachusetts  02116
United States
Contact: Stefany Mendez

Online registration is closed.
« Go to Upcoming Event List  

The 7th Annual ALPFA Healthcare Summit, “Disruptors in Healthcare and Life Sciences: How They Are Impacting Our Communities" will focus on current healthcare and life sciences topics that are affecting the Latino community. Subject matter experts from four distinct fields will present TED Talk style presentations on: medical technology innovations, partnerships and collaborations, reorientation in the pharmaceutical industry and the opioid epidemic. The Summit will open with a career fair that includes our healthcare and life sciences sponsors and other industry employers interested in recruiting diverse talent. A networking reception will follow the presentations. 

The 2017 summit will feature TED talk style presentations that will focus on:

1)      Partnership and Collaborations: Industry convergence is playing a vital role in the healthcare landscape. The industry is being transformed by partnerships, joint ventures, mergers, acquisitions and strategic alliances. Moreover, the 2016 Deloitte M&A Trends report expected 84% of convergence to happen in cross-related sectors such as pharma, healthcare and life sciences. For example, clinical affiliations between health systems and health insurance companies now exist with the shared goal of shifting care models from pay-for-service to pay-for-performance.

 Speaker: Christina Severin, President and CEO, Community Care Coorperative


2)      Medical Technology Innovations: Advancements in technology are changing healthcare delivery. One of the biggest advantages of technology is the use of clinical data analytics to improve the delivery of medical services by supporting providers in the evaluation, planning, and execution stages. A McKinsey Global Institute study revealed that the use of data analytics could help save more than $300 billion in U.S. healthcare. Apart from making information flow more transparently and creating a value chain in healthcare, other innovations in healthcare technologies such as artificial intelligence, virtual reality, and wearables are not only positively disruptive but also have the potential to change the face of healthcare in 2017 and transform our future by making healthcare more accessible to everyone, regardless of their geographic location.

Speaker: Anne Marie ConwayVP of Clinical Operations at Agilis Biotherapeutics and Faculty member at Suffolk University Sawyer Business School


3)      Opioid Epidemic: According to the American Society of Addiction Medicine, drug overdose is the leading cause of accidental death in the US with opioid related overdoses accounting for 63% of the 52,000 deaths in 2015. In Massachusetts, opioid related deaths have increased by 350% since 2000. As the federal government has proposed a 95% budget cut for the Office of National Drug Control Policy, individual states are acting independently to ameliorate their respective states epidemics. The Baker administration has introduced many new legal measures to combat the Commonwealth’s opioid epidemic. For example, Massachusetts enacted the first law in the nation to establish a 7-day limit on first-time opioid prescriptions. The opioid epidemic is a broad crisis that cuts across every sector of society. To further implement solutions that effectively meet the needs of our community, a collaborative approach  from stakeholders  healthcare providers, insurers, community leaders and all levels of government is needed.

Speaker:  Dr. Mark Libon, VP of Behavioral Health Service, Dimock Health Center


 4)      Using Data Analytics to Advance Drug Discover: Pharmaceutical companies are leveraging population health along with emerging genetic technologies to advance drug discovery personalized to specifics communities. The use of data analytics and precision medicine is changing how pharmaceutical companies operate and engage with patients. Join us at the Summit to learn about genetic studies and how one could leverage it in the Latino population

Speaker:   Georgia McGaughey, Senior Director, Vertex Pharmaceutical

Who should attend?  Any person working in the following fields:

·         Health insurance

·         Pharmaceutical

·         Life Sciences

·         Physician and hospitals

·         Health Policy


Expected Outcomes for Participants:

·         Educate the audience on emergent healthcare and life sciences trends

·         Gain exposure to prominent healthcare, life sciences, and government and policy leaders through TED style talks and small group direct interaction with speakers

·         Expand professional and personal networks

·         Obtain a renewed sense of presence, passion, and strength to continue building their leadership skills

·         Identify role models and informal mentors


Event Details

·Date: November 9th, 2017


o   Career Fair: 4:00 – 6:30 p.m.

o   Summit: 6:30 – 9:00 p.m.

·Location: MassDot, 10 Park Plaza, Executive Room, Boston, MA 02116

  •  Parking:  There are a few parking lots nearby: CityPlace Garage (8 Park Plaza), Motor Mart Garage (201 Stuart St), and 200 Stuart Street Garage
  • Public Transportation: The closest T stop are Boylston St or Arlington St on the Green Line

Agenda at a Glance (subject to change)

4:00 p.m.                   Doors Open

4:00 – 6:30 p.m.        Registration, Career Fair and Network Reception

6:30 – 6:40 p.m.        Welcome Remarks

6:40 – 7:00 p.m.        Speaker #1: Partnership and Collaborations

                                        Christina Severin, President and CEO, Community Care Coorperative

7:00 – 7:20 p.m.        Speaker #2: Medical Technologies Innovation

                                         Anne Marie ConwayVP of Clinical Operations at Agilis Biotherapeutics and Faculty member at Suffolk University Sawyer Business School

7:20 - 7:40 p.m.         Speaker #3: Opioid Epidemic

                                        Dr. Mark Libon, VP of Behavioral Health Service, Dimock Health Center

7:40 – 8:00 p.m.        Speaker #4: Using Data Analytics to Advance Drug Discovery

                                         Georgia McGaughey, Senior Director, Vertex Pharmaceutical

8:00 - 8:20 p.m.         Questions and Answers

8:20 – 8:30 p.m.        Closing Remarks

8:30 – 9:00 p.m.        Network Reception

9:00 p.m.                   Program Concludes


Host Sponsor:


Power of Innovation Sponsors:




Community Health Sponsors:



Public Health Sponsors:



Career Fair Sponsors:

·         BCBSMA

·         Fenway Health

·         Harvard Pilgrim Health Care

·         Suffolk University – Sawyer Business School



#1: Partnership and Collaborations

Christina Severin, President and CEO, Community Care Coorperative

   Christina Severin is an accomplished health care executive with more than 20 years of experience in managed care, delivery systems, health insurance, Accountable Care Organizations, quality, public policy, and public health.  Christina’s prior leadership experience includes having served as President and Chief Executive Officer of Beth Israel Deaconess Care Organization and as President of Network Health, a nonprofit Massachusetts health plan.  

She is widely recognized, including by the Boston Globe as a Top 100 Women-Led Business, October, 2015. The Boston Business Journal has recognized Christina as a “40 Under 40” honoree, profiled her in its “Women Up” feature, and named her to its list of top health care executives to change roles in 2013.

Christina has taught classes in health care administration and management at Boston University, Harvard University, and Northeastern University. Christina earned a Master of Public Health with a concentration in Health Services from Boston University School of Public Health, and a Bachelor of Arts in Political Economy from the University of Massachusetts at Amherst.

#2: Medical Technologies Innovation

Anne Marie Conway, VP of Clinical Operations at Agilis Biotherapeutics and Faculty member at Suffolk University Sawyer Business School

 Professor Conway co-teaches Innovation: The Future of Healthcare with Professor Gregg. She is a registered nurse and a graduate of Suffolk’s MHA Program. She serves as a consultant to pharmaceutical and biotechnology companies, providing global clinical program management, vendor outsourcing, clinical budget and timeline development, mentoring and executive management. Previously, she held senior-level management positions at Ziopharm Oncology and Shire Human Genetic Therapies. Shire is a biopharmaceutical company that develops new treatments for rare genetic conditions. From 2001 until 2010, she held several leadership roles, including vice president of development operations, and she was involved with clinical program management, business operations, medical writing, and data management. She led integrated cross-functional teams, resulting in three biologic license application /new drug application filings and subsequent approvals, as well as supplemental new drug applications that led to label changes. Before joining Shire, she spent nearly 20 years at Tufts Medical Center, where she served as a staff nurse, outpatient nurse coordinator, and clinical trials manager. During her time there, she oversaw 15 Phase II-IV studies within the Division of Gastroenterology.


In addition to her work in the healthcare field, Professor Conway is a member of the advisory board for the Medical Legal Partnership | Boston. MLP | Boston addresses the complex social determinants of patients’ health and ensures that low-income patients are able to meet their basic needs for food, housing and utilities, education and employment, healthcare, and personal and family stability and safety. She has given presentations around the world on various topics, including clinical trials management, women making a difference in healthcare innovation, Gaucher disease, hepatitis C, and the legal and ethical aspects of informed consent. Her clinical background and administrative experience provides valuable insight on the current and future challenges in the healthcare industry.


#3: Opioid Epidemic

Dr. Mark Libon, VP of Behavioral Health Services of the Dimock Health Center

 Mark Libon, Ph.D., LMHC, LMFT, LADC 1 is the Vice President of Behavioral Health Services at The Dimock Center. He has close to 30 years of experience in the behavioral health field. He is a Licensed Mental Health Counselor, a Licensed Marriage and Family Therapist and a Licensed Alcohol and Drug Counselor. Dr. Libon oversees all of Dimock’s Behavioral Health programs, including our continuum of substance use treatment (inpatient detoxification, residential recovery and outpatient services). This division also includes health-center based psychiatry and other mental health services; community residential and support programs for adults with development disabilities; a family shelter; and transitional and permanent residences in the community for parents in recovery and their children. Dr. Libon oversees Dimock’s integration of Behavioral Health Services and Medicine in our community health center. He holds a B.A. in Psychology from the University of New Hampshire, a Master’s Degree in Developmental Clinical Psychology from Antioch University and a Ph.D. in Clinical Psychology from the California School of Professional Psychology.


#4: Pharmaceutical Industry

Georgia McGaughey, Senior Director, Vertex Pharmaceutical

Georgia McGaughey is the Senior Director of the global Modeling & Informatics group at Vertex Pharmaceuticals Inc., comprised of molecular modeling, informatics and methods development.  She is also a member of the Research Leadership Team, which sets the strategy for the research arm of the company.  Through her twenty-year career in pharmaceuticals (Wyeth, Merck, Vertex) Georgia has contributed to the invention and advancement of several clinical candidates (e.g. BACE, orexin, PDE10, CFTR and KDR) and has contributed to more than 100 publications and presentations. She is a past member of the editorial advisory board for the Journal of Medicinal Chemistry and participant of multiple study sections for the NIH. Currently, she volunteers in the Boston scientific community through mentorship with high school and college students, is an editorial board member of F1000 and recently joined Silent Spring Institute as a board member.  Georgia earned her B.S. degree in chemistry from Kennesaw State College and her Ph.D in physical chemistry from the University of Georgia.  She carried out her post-doctoral studies with focus on electronic structure theory at Colorado State University.  She is also an avid runner and plays the piano.




Get In Touch
801 South Grand Avenue
Suite 400
Los Angeles, CA 90017
1.855.MYALPFA ex 713
Stay Connected
Make A Donation